The research interests of Bradford (Brad) S. Hoppe, M.D., focus on improving therapeutic ratio in the management of lymphoma and solid cancers by reducing the risk of toxicities from radiation, while simultaneously trying to improve cure and overall survival with proton therapy. His research contributions have helped shape the national management guidelines for prostate cancer, lymphoma, and head and neck cancer.
- Using particle therapy to improve overall survival among patients with lung cancer
- Improving the therapeutic ratio in the management of Hodgkin's and non-Hodgkin's lymphoma
- Understanding radiation-induced heart disease and mechanisms for minimizing injury and therapeutic options
- Improving the quality of life in patients with prostate cancer through the use of radiotherapy
Significance to patient care
Dr. Hoppe's research efforts aim to maximize the therapeutic effect from radiotherapy, while identifying ways to minimize the harmful effects of treatment.
- Senior editor, Advances in Radiation Oncology, 2015-present
- Radiation Oncology Chair, Lymphoma Subcommittee, Particle Therapy Co-Operative Group (PTCOG), 2013-present
- Secretary, PTCOG North America, 2012-present
- Radiation Oncology Chair, Pediatric Hodgkin Lymphoma Group, Children's Oncology Group, 2012-2018
- Awarded, James E. Lockwood Jr. Professorship in Proton Therapy, University of Florida College of Medicine-Jacksonville, 2013